Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Liliam L. Pineda"'
Autor:
Riruke Maruyama, Takayuki Harada, Akinobu Nakano, Cem Sezer, Masaaki Iijima, Asuka Araki, Li Zhou, Liliam L. Pineda, Manabu Yoshida
Publikováno v:
Pathology International. 53:726-732
A 19-year-old man with mild mental retardation was diagnosed as having metastatic choriocarcinoma and a testicular tumor. Histopathological examination of the resected testis revealed the presence of a small lesion of mature teratoma but no trace of
Autor:
Masahiro Wada, Akinobu Nakano, Takayuki Harada, Masaaki Iijima, Yoji Yamasaki, Liliam L. Pineda
Publikováno v:
Pathology International. 53:390-395
We describe changes in the immune system of the newly established mutant line, ataxia and male sterility (AMS) mouse, and that the putative ams mutation is independent of lpr but seemed to affect lymphoproliferation in its mother strain, MRL/lpr. The
Autor:
Masaaki Iijima, Minesuke Yokoyama, Koji Omura, Takayuki Harada, Liliam L. Pineda, Li Zhou, Akinobu Nakano, Yoji Yamasaki
Publikováno v:
Pathology International. 53:382-389
We describe a novel genetic variant mouse that exhibited ataxia and male sterility, named the AMS mouse. It arose in autoimmune-prone MRL/lpr strain and putative ams mutation showed an autosomal recessive inheritance pattern. Clinical symptoms were f
Publikováno v:
Proceedings of The Japanese Society of Animal Models for Human Diseases. 19:1-6
A novel genetic variant mouse, which exhibited ataxia and male sterility named AMS mouse, arising in autoimmune-prone MRL/lpr is described. Inheritance pattern of mutation and linkage between ams and lpr genes: The phenotype expression of the AMS tra
Autor:
Hisashi Masuda, Takayuki Harada, Taiji Takanashi, Liliam L. Pineda, Akihiro Ohira, Yuzo Shibuya
Publikováno v:
Scopus-Elsevier
Publikováno v:
Developmental Biology. (2):608-609
Autor:
Marquez L; Janssen Research and Development, LLC, Raritan, NJ, USA. lmarquez@its.jnj.com., Raheja R; AbbVie, North Chicago, IL, USA., Chan-Liston M; Bristol Myers Squibb, Lawrenceville, NJ, USA., Marcinak J; AbbVie, North Chicago, IL, USA., Estilo A; Otsuka Pharmaceutical Development, Inc. (OPDC), Princeton, NJ, USA., Pineda Salgado L; Otsuka Pharmaceutical Development, Inc. (OPDC), Princeton, NJ, USA., Jiang J; Daiichi Sankyo, Inc., Basking Ridge, NJ, USA., Chang C; Takeda, Cambridge, MA, USA., Beninger P; Public Health and Community Medicine, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA, 02111, USA.
Publikováno v:
Drug safety [Drug Saf] 2024 Jan; Vol. 47 (1), pp. 1-22. Date of Electronic Publication: 2023 Oct 24.
Autor:
Pineda Salgado L; Otsuka Pharmaceutical Development & Commercialization, Inc., 508 Carnegie Center, Princeton, NJ, 08540, USA. Liliam.PinedaSalgado@otsuka-us.com., Gupta R; Otsuka Pharmaceutical Development & Commercialization, Inc., 508 Carnegie Center, Princeton, NJ, 08540, USA.; Vitrana Inc., Cranbury, NJ, 08512, USA., Jan M; Otsuka Pharmaceutical Development & Commercialization, Inc., 508 Carnegie Center, Princeton, NJ, 08540, USA., Turkoglu O; Otsuka Pharmaceutical Development & Commercialization, Inc., 508 Carnegie Center, Princeton, NJ, 08540, USA., Estilo A; Otsuka Pharmaceutical Development & Commercialization, Inc., 508 Carnegie Center, Princeton, NJ, 08540, USA., George V; Otsuka Pharmaceutical Development & Commercialization, Inc., 508 Carnegie Center, Princeton, NJ, 08540, USA., Rahman MI; Otsuka Pharmaceutical Development & Commercialization, Inc., 508 Carnegie Center, Princeton, NJ, 08540, USA.
Publikováno v:
Advances in therapy [Adv Ther] 2021 Sep; Vol. 38 (9), pp. 4709-4721. Date of Electronic Publication: 2021 Jul 28.
Autor:
Hey-Hadavi J; Pfizer, 235 E 42nd Street, New York City, NY, 10017, USA. Judith.Hey-Hadavi@pfizer.com., Seekins D; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Palmer M; Takeda, Cambridge, MA, USA.; Liver Consulting LLC, New York City, USA., Coffey D; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Caminis J; Sanofi, Bridgewater, NJ, USA., Abdullaev S; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Patwardhan M; AbbVie, North Chicago, IL, USA., Tyler H; Otsuka Pharmaceutical Development and Commercialization, Inc., 508 Carnegie Center Dr, Princeton, NJ, 08540, USA., Raheja R; AbbVie, North Chicago, IL, USA., Stanley AM; IQ DILI Consortium, Washington, DC, USA., Pineda-Salgado L; Otsuka Pharmaceutical Development and Commercialization, Inc., 508 Carnegie Center Dr, Princeton, NJ, 08540, USA., Bourdet DL; Theravance Biopharma, South San Francisco, CA, USA., Andrade RJ; Unidad de Gestión Clínica de Aparato Digestivo, Instituto de Investigación Biomédica de Málaga-IBIMA, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Málaga, Spain., Hayashi PH; University of North Carolina, Chapel Hill, NC, USA., Dimick-Santos L; US Food and Drug Administration, Silver Spring, MD, USA., Rockey DC; Medical University of South Carolina, Charleston, SC, USA., Estilo A; Otsuka Pharmaceutical Development and Commercialization, Inc., 508 Carnegie Center Dr, Princeton, NJ, 08540, USA. Alvin.Estilo@otsuka-us.com.
Publikováno v:
Drug safety [Drug Saf] 2021 Jun; Vol. 44 (6), pp. 619-634. Date of Electronic Publication: 2021 Mar 16.
Autor:
Steiner AB; Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA., Engleka MJ, Lu Q, Piwarzyk EC, Yaklichkin S, Lefebvre JL, Walters JW, Pineda-Salgado L, Labosky PA, Kessler DS
Publikováno v:
Development (Cambridge, England) [Development] 2006 Dec; Vol. 133 (24), pp. 4827-38. Date of Electronic Publication: 2006 Nov 08.